&lt;p&gt;“Faster diagnosis, better outcomes: Biosensors pave the way for a brighter future for cancer patients”. As one of the top causes of death worldwide, cancer must be addressed with the help of innovative treatments and state-of-the-art diagnostic techniques. Due to stress, poor lifestyle choices, and environmental factors, cancer incidence is worryingly on the rise in India, especially among the younger generation. In India, 1 in 5 persons may receive a cancer diagnosis by 2025, potentially impacting 1.57 million people, even though 30–50% of cancers are preventable. Even though standard screening techniques are frequently too costly and impracticable for everyday use, early detection is vital. Alternatives that show promise include emerging biosensor technologies, which give quick, accurate, and customized diagnostic results. Due to its capacity to quickly and automatically identify biological changes, ultra-sensitive biosensing systems utilizing single chips have revolutionized cancer detection. Since they are more effective than conventional techniques, point-of-care (PoC) biosensors—such as innovative nano-sensing devices for exosomal micro-RNA analysis—are becoming increasingly popular. Developing sophisticated diagnostic instruments like bio-computers and resonant mirrors is made easier by these biosensors, which combine analytes, receptors, and electrical sensors to detect cancer biomarkers in biological samples. The accuracy and usability of detection are further improved by advancements in wearable technologies, microfluidics, and electrochemical and graphene-based sensors. BrCyS-Q and NanoLiposomes provide improved photodynamic treatment and targeted medication delivery, respectively. Improved patient outcomes and early intervention are anticipated using the i-Genbox, a colorimetric sensor based on LAMP technology, and DNA-SWCNT-based sensors that further improve biomarker identification for gynecologic tumors.&lt;/p&gt;

Dinesh Bhatia

Tania Acharjee

Monika Bhatia

AIMS Biophysics

AIMS Biophysics is an international Open Access journal devoted to publishing peer-reviewed, high quality, original papers in the field of biophysics. We publish the following article types: original research articles, reviews, editorials, letters, and conference reports.    AIMS Biophysics welcomes, but not limited to, the papers from the following topics:    · Structural biology  · Biophysical technology  · Bioenergetics  · Membrane biophysics  · Cellular Biophysics  · Electrophysiology  · Neuro-Biophysics  · Biomechanics  · Systems biology

AIMS Biophysics is an international Open Access journal dedicated to publishing peer-reviewed, high-quality original papers in the field of biophysics. We publish various types of articles, including original research articles, reviews, editorials, letters, and conference reports. AIMS Biophysics welcomes papers on a wide range of topics, including but not limited to: structural biology, biophysical technology, bioenergetics, membrane biophysics, cellular biophysics, electrophysiology, neuro-biophysics, biomechanics, and systems biology.

《AIMS Biophysics》是一本国际开放获取期刊，致力于发表经过同行评审的高质量原创论文，涵盖生物物理学领域。我们接受以下类型的文章：原创研究文章、综述、社论、信件和会议报告。《AIMS Biophysics》欢迎但不限于以下主题的论文：结构生物学、生物物理技术、生物能量学、膜生物物理学、细胞生物物理学、电生理学、神经生物物理学、生物力学和系统生物学。

Advancements in nanosensors for cancer detection

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info

Category	Quartile
BIOPHYSICS	4